Bolt raises $54M series B

Autoimmune company Bolt Biotherapeutics Inc. (Redwood City, Calif.) raised $54 million in a series B round led by Pivotal bioVenture Partners. Nan Fung Life Sciences along with existing investors Novo Holdings and Vivo Ventures also participated...